Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+31.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.10 | +124.7% |
| 2024 | 0.04 | +19.6% |
| 2023 | 0.04 | -15.5% |
| 2022 | 0.04 | - |
| 2021 | 0.00 | +100.0% |
| 2020 | -0.17 | - |
| 2019 | 0.00 | - |